BEIJINGChina will scrap caps on retail prices for lowcost medicine and is moving toward freemarket pricing for pharmaceuticals after price controls led to drug quality problems and shortages in the country  The move could be a welcome one for global pharmaceutical companies which have been under scrutiny in China since last year for their sales and marketing practices  The
  